Effect of Chicken Egg Antibody (IgY) on Patients With Chronic Gastritis

Immunology Research Institute in Gifu

Status: Completed

Conditions: Chronic Gastritis Caused by Helicobacter Pylori

Treatments: Dietary Supplement: GastimunHP

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT02721355

BV108-15

Details and patient eligibility

About

H. pylori positive patient volunteers that passed the selection criteria are recruited and divided into a test and a control group. Both groups are treated with a current treatment regime (EAC: Esomeprazole 40 mg/day; Clarithromycin 1000 mg/day; Amoxicillin 2000 mg/day) but only the test group received IgY-containing food supplement as an adjunctive measure for 15 days. The subjects are examined before and 4 weeks after the treatment initiation by Urea Breath Test (UBT) and gastro-endoscopy.

Enrollment: 84 patients

Sex: All

Ages: 2+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with gastritis or gastric ulcer who are positive to H. pylori

Exclusion criteria

• People allergic to egg proteins

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

84 participants in 2 patient groups

Food supplement GastimunHP

Experimental group

Description:

The subjects take food supplement containing specific IgY (GastimunHP) during treatment with routine medical regime

Treatment:

Dietary Supplement: GastimunHP

Control

No Intervention group

Description:

The subjects undergo the routine treatment regime without taking food supplement